2006
DOI: 10.1016/j.vaccine.2005.11.061
|View full text |Cite
|
Sign up to set email alerts
|

The FML-vaccine (Leishmune®) against canine visceral leishmaniasis: A transmission blocking vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
76
1
8

Year Published

2009
2009
2018
2018

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 99 publications
(86 citation statements)
references
References 38 publications
1
76
1
8
Order By: Relevance
“…These antibodies, after ingestion by the vector during the blood meal, are thought to block the parasite fertilization process in the vector by competing with Leishmania to bind to the vector's midgut, with significant results for L. infantum and L. chagasi (Saraiva et al 2006). These findings demonstrated that the vaccine is a potential vector transmission blocker, opening a new perspective for VL control through vector transmission blocking (Dantas-Torres 2006).…”
Section: Insecticidal Plantsmentioning
confidence: 95%
See 1 more Smart Citation
“…These antibodies, after ingestion by the vector during the blood meal, are thought to block the parasite fertilization process in the vector by competing with Leishmania to bind to the vector's midgut, with significant results for L. infantum and L. chagasi (Saraiva et al 2006). These findings demonstrated that the vaccine is a potential vector transmission blocker, opening a new perspective for VL control through vector transmission blocking (Dantas-Torres 2006).…”
Section: Insecticidal Plantsmentioning
confidence: 95%
“…Although this measure is focused directly on the canine reservoir, experimental studies have demonstrated that Lu. longipalpis females fed on vaccinated dogs can develop receptors for the antibodies produced by the vaccine antigen fucose-mannose ligand (FML), preventing new forms of Leishmania chagasi ingested by the insect in other blood meals (Saraiva et al 2006). This study was based on previous experiments to produce a "transmission blocker" vaccine against malaria (Arévalo-Herrera & Herrera 2001).…”
Section: Insecticidal Plantsmentioning
confidence: 99%
“…In regard to proteins expressed on the surface of parasites (other than Plasmodium) transmitted to humans by insect vectors (Table 2), only a limited number has been tested as potential TBVs (Tonui et al 2001a;Saraiva et al 2006). …”
Section: Other Pathogen Molecule-based Tbv Candidatesmentioning
confidence: 99%
“…Interestingly, a commercially available treatment for canine visceral leishmaniasis (Leishmune ® ) was recently shown to function as a TBV in sand flies (Saraiva et al 2006). Leishmune ® (FML-vaccine) is a protective vaccine made of L. donovani fucose-manose ligand and the adjuvant saponin, which was successfully tested in a phase III vaccine trial (da Silva et al 2000).…”
Section: Other Pathogen Molecule-based Tbv Candidatesmentioning
confidence: 99%
See 1 more Smart Citation